Abstract A033: Leveraging mass cytometry for phenotyping CTCs in SCLC liquid biopsies: Tracking therapy resistance at a personalized level

• Published in: Clinical cancer research Vol. 30; no. 21_Supplement; p. A033
• Main Authors: Karacosta, Loukia G, Bhattacharyya, Sayantan, Stewart, Allison, Victorian, Ashley, Lujan, Ester F, Ehsan, Shafqat, Kim, Subin, Duarte, Alberto, Wang, Runsheng, Anchang, Benedict, Wang, Jing, Byers, Lauren
• Format: Journal Article
• Language: English
• Published: 13-11-2024
• ISSN: 1557-3265; 1557-3265
• DOI: 10.1158/1557-3265.LIQBIOP24-A033

This abstract is being presented as a short talk in the scientific program. A full abstract is printed in the Proffered Abstracts section (PR005) of the Conference Program/Proceedings.
Citation Format: Loukia G Karacosta, Sayantan Bhattacharyya, Allison Stewart, Ashley Victorian, Ester F Lujan, Shafqat Ehsan, Subin Kim, Alberto Duarte, Runsheng Wang, Benedict Anchang, Jing Wang, Lauren Byers. Leveraging mass cytometry for phenotyping CTCs in SCLC liquid biopsies: Tracking therapy resistance at a personalized level [abstract]. In: Proceedings of the AACR Special Conference: Liquid Biopsy: From Discovery to Clinical Implementation; 2024 Nov 13-16; San Diego, CA. Philadelphia (PA): AACR; Clin Cancer Res 2024;30(21_Suppl):Abstract nr A033.